Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Shareholders' Equity (Details) - Schedule of Weighted Average Exercise Prices Share Options

v3.24.1
Shareholders' Equity (Details) - Schedule of Weighted Average Exercise Prices Share Options - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2023
Schedule of Weighted Average Exercise Prices Share Options [Abstract]    
Number of options, Granted (in Shares)   55,500,000
Weighted average exercise price, Granted   $ 0.01
Weighted average remaining contractual terms, Granted   10 years
Aggregate intrinsic value , Granted  
Number of options, Forfeited/expired (in Shares)   (25,200)
Weighted average exercise price, Forfeited/expired  
Aggregate intrinsic value, Forfeited/expired  
Number of options, Ending (in Shares) 27,002,200 82,477,000
Weighted average exercise price, Ending $ 0.13 $ 0.04
Weighted average remaining contractual terms, Ending 7 years 1 month 20 days 8 years 4 months 24 days
Aggregate intrinsic value, Ending (in Dollars)
Number of options, Vested and expected to vest (in Shares)   82,477,000
Weighted average exercise price, Vested and expected to vest   $ 0.04
Weighted average remaining contractual terms, Vested and expected to vest   8 years 4 months 24 days
Aggregate intrinsic value, Vested and expected to vest (in Dollars)  
Number of options, Exercisable (in Shares)   24,280,125
Weighted average exercise price, Exercisable   $ 0.11
Weighted average remaining contractual terms, Exercisable   7 years 2 months 15 days
Aggregate intrinsic value, Exercisable (in Dollars)